Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of South Alabama
Mobile, Alabama, United States
- Mount Sinai Medical Center of Florida
Miami Beach, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- University of Chicago
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Northshore University Healthsystem
Evanston, Illinois, United States
- Oncology Specialists S.C.
Park Ridge, Illinois, United States
- Illinois Cancer Care
Peoria, Illinois, United States
- Fort Wayne Medical Oncology and Hematology, Inc.
Fort Wayne, Indiana, United States
- Virginia Commonwealth University/ Massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Jun 2016
- Primary completion
- 1 Jun 2022
- Completion
- 30 Jun 2026
- Last update posted
- 10 Jun 2025
- Registered enrollment
- 70
- Registry id
- NCT02743819
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.